Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Medtronic
Boehringer Ingelheim
McKinsey
Johnson and Johnson

Last Updated: June 27, 2022

Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)


✉ Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .

Details for ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-09-21 10 THE PATENTS-IN-SUIT 26. United States Patent No. 6,774,122 (the “’122 Patent”), entitled… the expiration of AstraZeneca’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. … COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,774,122 40. Plaintiffs hereby reallege… U.S. PATENT NO. 6,774,122 51. Plaintiffs hereby reallege… This is a civil action for patent infringement under the patent laws of the United States, Title External link to document
2016-09-02 120 Formulations, 52 J. Pharm. Sci. Tech. • U.S. Patent No. 6,417,191, AZF2_00005454–66 …Statement for U.S. Patent Nos. 6,774,122 (“the ’122 Patent”), 7,456,160 (“the ’160 Patent”), 8,329,680 (… (“the ’680 Patent”), and 8,466,139 (“the ’139 Patent”) (collectively, “the Patents-in-Suit”) in the…disputed term in the ’122 Patent (Exhibit A), the ’160 Patent (Exhibit B), the ’680 Patent (Exhibit C), and…these Hatch-Waxman patent actions, Plaintiffs are asserting infringement of the Patents-in-Suit against External link to document
2017-01-04 197 enjoined from infringing United States Patent Numbers 6,774,122, 7,456,160, 8,329,680 and 8,466,139, on…2015 27 October 2017 1:15-cv-06039 830 Patent None District Court, D. New Jersey External link to document
2015-12-07 29 the expiration of the Plaintiff’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. …law and fact in so much as they are actions for patent infringement Case 1:15-cv-06039-RMB-KMW Document…2015 27 October 2017 1:15-cv-06039 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
AstraZeneca
Boehringer Ingelheim
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.